期刊文献+

多种药物联合膀胱灌注预防膀胱癌复发的临床研究 被引量:12

Clinical study of irrigation of bladder with multiple drugs to preclude the recurrence of carcinoma of bladder
下载PDF
导出
摘要 目的探讨多种药物联合膀胱灌注与单种药物膀胱灌注预防膀胱癌复发疗效的差异及其安全性。方法对符合入选标准的106例非肌层浸润性膀胱移行细胞癌患者,术后1周按随机数字法分为3组进行膀胱内灌注。羟基喜树碱(HCPT)组36例,HCPT20mg+生理盐水60ml膀胱灌注;顺铂(DDP)组32例,DDP60mg+生理盐水60ml膀胱灌注;HCPT+DDP组38例,DDP60mg+生理盐水60ml膀胱灌注,3d后HCPT20mg+生理盐水60ml膀胱灌注。每周1次,共8次;以后每个月1次,至满1年,每次药物在膀胱内保留60min。术后定期行膀胱镜检查,观察有无肿瘤复发。结果106例患者,术后随访6~30个月。HCPT组36例患者中复发12例,DDP组32例患者中复发11例,HCPT+DDP组38例患者中复发5例,3组相比差异具有统计学意义(P<0.05)。而各组之间不良反应的发生率差异无统计学意义(P>0.05)。结论HCPT联合DDP灌注化疗对预防膀胱癌术后复发的效果优于单用HCPT或DDP,但其不良反应以及是否适宜广泛应用还需作进一步的研究。 Objective To evaluate the difference of treatment effect of irrigation of bladder with multiple drugs( HCPT and DDP) to prevent the recurrence of carcinoma of bladder. Methods One hun-dred and six patients with bladder cancer were prospectively enrolled and randomized into 3 group. Thirty six cases in HCPT group were treated with irrigation of HCPT 20 mg in normal sodium 60 ml. Thirty two cases in DDP group were treated with irrigation of DDP 60 mg in normal sodium 60 ml. Thirty eight cases in HCPT plus DDP group were treated with irrigation of DDP 60 mg in normal sodium 60 ml, and with irrigation of HCPT 20 mg in normal sodium 60 ml after 3 days. They were instilled within two weeks after operation, once a week for eight weeks, followed by once a month till one year. Regular cystoseopy was performed for the follow-up examination. Results All patients were followed up for 6 to 30 months. Among the 36 cases in HCPT group, recurrence was seen in 12 cases;Among the 35 cases in DDP group, recurrence was seen in 11 cases; Among the 38 cases in HCPT plus DDP group, recurrence was seen in 5 cases; The difference between the three groups is significant(P〈0.05). And there was no significant difference between them in complication(P〉0.05). Conclusions HCPT combined with DDP would be more effective than HCPT combined or DDP alone in prevention of recurrence of bladder cancer. Further study is needed for observation of their side effects and popularization in such way.
出处 《现代泌尿生殖肿瘤杂志》 2009年第2期91-93,共3页 Journal of Contemporary Urologic and Reproductive Oncology
关键词 膀胱肿瘤 膀胱灌注 羟基喜树碱 顺铂 复发 Bladder neoplasms Bladder instillation Hydroxycamptothecin Cisplatin Recurrence
  • 相关文献

参考文献3

二级参考文献40

  • 1Chou TC,Talalay P.Quantitative analysis of dose-effect relationships:the combined effects of multipl(e) drugs or enzyme inhibitiors[J].Adv Enzym Regul,1984,22:27-55.
  • 2Tantivejkul K,Vucenik I,Eiseman J,et al.Inositol hexaphos phate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer[J].Breast cancer research and treatment,2003,79(3):301-312.
  • 3Vu MD,Qi S.Wang X,etal.Combination therapy of malononitrilamide FK778 with tacrolimus on cellproliferation assays and in rats receiving renal allografts[J].Transplantation,2003,75(9):1455-1459.
  • 4Bellmunt J,Cos J,Cleries R,et al.Feasibility trial of methotrexate-paclitaxel as a second line therapy inadvanced urothelial cancer[J].Cancer investigation.2002,20 (5):673-685.
  • 5Perez,EA,Buckwalter,CA.Sequence-dependent cytotoxicity of etoposide and paclitaxel in human breastand lung cancer cell lines[J].Cancer Chemotherapy and Pharmacology,1998,41(6):448-452.
  • 6Mosmann T.Rapid colorimetric assay for cellulat growth and survival:applicatior to proliferation and cytotoxicity assays[J].J Immunol Methods,1983,65:55-63.
  • 7Lunardi G,Vannozzi MO,Bighin C,et al.Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breastcancer patients[J].Annals of oncology,2003,14(8):1222-1226.
  • 8Lum BL,Torti FM.Adjuvant intravesical pharmacology for superficial bladder cancer.J Natl Cancer Inst,1991,83(10):682-694.
  • 9Tolley DA,Hargreave TB,Smith PH,et al.Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer:interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).Br Med J,1988,296(6639):1759-1761.
  • 10Melekos MD,Dauaher H,Fokaefs E,et al.Intravesical instillations of 4-epi-doxorubicin (epirubicin) in the prophylactictreatment of superficial bladder cancer:results of a controlled prospective study.J Urol,1992,147(2):371-375.

共引文献20

同被引文献96

  • 1孙祥宙,邓春华,戴宇平,丘少鹏.沙培林膀胱灌注预防膀胱癌术后复发的机制[J].临床泌尿外科杂志,2004,19(7):407-409. 被引量:16
  • 2吴昀,高光霞.丝裂霉素致化学性膀胱炎1例[J].临床泌尿外科杂志,2006,21(3):212-212. 被引量:4
  • 3程旭,李清.膀胱癌术后膀胱灌注疗法的不良反应与处理[J].临床泌尿外科杂志,2007,22(5):389-390. 被引量:1
  • 4Amling CL.Diagnosis and management of superf icial bladder cancer.Curr Probl Cancer,2001,25(4):219.
  • 5Jema! A, Siegel R, Ward E, et al. Cancer statistics,2009 [J]. CA Cancer J Clin ,2009.59(4) :225-249.
  • 6Sylvester R J, van der Meijdcn AP, Oosterlinck W,et al. Predictingrecurrence and progression in individual patients with stage Ta T1bladder cancer using EORTC risk tables : a combined analysis of2596 patients from seven EORTC trials [J]. Eur Urol, 2006,49(3) :466-477.
  • 7Brausi M, Collette L, Kurth K,et al. Variability in the recurrencerate at first followup cystoscopy after TUR in stage Ta TItransilional cell carcinoma of the bladder: a combined analysis ofseven EORTC studies[J].Eur Urol,2002,41(5) :523-531.
  • 8Muraro GB, Grifoni R, Spazzafurno L. Endoscopic therapy of superficial bladder cancer in highrisk patients: Holmium laser versus transurethral resection [J]. Surg Technol Int, 2005,14 : 222-226.
  • 9Uchida A, Yonou H, Hayashi E,et al. Intravesical instillation ofbacille CalmetteGuerin for superficial bladder cancer: costeffectiveness analysis [J]. Urology,2007,69 (2) : 275-279.
  • 10Bohle A, Bock PR. Intravesicat bacille CalmetteGuefin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression [J].Urology, 2004,63 (4) :682-686.

引证文献12

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部